Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle T Amber

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Ocular Immunology and Inflammation|September 6, 2024
The Role of Serology in the Diagnosis of Ocular Predominant Mucous Membrane Pemphigoid and the Search for an Ocular-Specific AutoantigenDharm Sodha, Sabrina Patzelt, Ali R Djalilian, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 19, 2025
Frequency of venous thromboembolism in immunobullous disease patients treated with IVIG: A systematic reviewKevin Truong-Balderas, Nicole Nowak, Paige Adams, et al.
Frontiers in Immunology|August 10, 2019
The Risk of Pulmonary Embolism in Patients With Pemphigus: A Population-Based Large-Scale Longitudinal StudyKhalaf Kridin, Mouhammad Kridin, Kyle T Amber, et al.
Melanoma Research|October 21, 2016
A case report of bullous pemphigoid associated with a melanoma and review of the literatureKyle T Amber, Christine M Panganiban, Dorota Korta, et al.
Archives of Dermatological Research|February 9, 2020
Hidradenitis suppurativa and pemphigus: a cross-sectional studyKhalaf Kridin, Virginia A Jones, Payal M Patel, et al.
International Journal of Dermatology|March 18, 2026
Review of Low-Dose Naltrexone for Hailey-Hailey Disease Suggests Lack of Benefit in Dose EscalationYulu Wang, Haley R Gainer, Claudia Lasalle, et al.
Archives of Dermatological Research|March 9, 2021
Melanoma is associated with an increased risk of bullous pemphigoid: a large population-based longitudinal studyKhalaf Kridin, Jennifer E Hundt, Ralf J Ludwig, et al.
Experimental Dermatology|May 13, 2026
CD24 in Melanoma: Biomarker, Innate Immune Checkpoint and Emerging Therapeutic TargetClaudia Lasalle, Rachel C Chang, Nicole C Nowak, et al.
Archives of Dermatological Research|May 21, 2025
The impact of health insurance delays on biologic therapy access in autoimmune bullous disease: a single-center retrospective analysisPaige E Adams, Elise K Brunsgaard, Nikki Rezania, et al.
Oncoscience|March 20, 2026
Targeting MD2 in prostate cancer bone metastasis: Mechanistic insights and therapeutic potentialMelina A Dattilo, Marina G Ferrari, Alexis P Jimenez-Uribe, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Ocular Immunology and Inflammation|September 6, 2024
The Role of Serology in the Diagnosis of Ocular Predominant Mucous Membrane Pemphigoid and the Search for an Ocular-Specific AutoantigenDharm Sodha, Sabrina Patzelt, Ali R Djalilian, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 19, 2025
Frequency of venous thromboembolism in immunobullous disease patients treated with IVIG: A systematic reviewKevin Truong-Balderas, Nicole Nowak, Paige Adams, et al.
Frontiers in Immunology|August 10, 2019
The Risk of Pulmonary Embolism in Patients With Pemphigus: A Population-Based Large-Scale Longitudinal StudyKhalaf Kridin, Mouhammad Kridin, Kyle T Amber, et al.
Melanoma Research|October 21, 2016
A case report of bullous pemphigoid associated with a melanoma and review of the literatureKyle T Amber, Christine M Panganiban, Dorota Korta, et al.
Archives of Dermatological Research|February 9, 2020
Hidradenitis suppurativa and pemphigus: a cross-sectional studyKhalaf Kridin, Virginia A Jones, Payal M Patel, et al.
International Journal of Dermatology|March 18, 2026
Review of Low-Dose Naltrexone for Hailey-Hailey Disease Suggests Lack of Benefit in Dose EscalationYulu Wang, Haley R Gainer, Claudia Lasalle, et al.
Archives of Dermatological Research|March 9, 2021
Melanoma is associated with an increased risk of bullous pemphigoid: a large population-based longitudinal studyKhalaf Kridin, Jennifer E Hundt, Ralf J Ludwig, et al.
Experimental Dermatology|May 13, 2026
CD24 in Melanoma: Biomarker, Innate Immune Checkpoint and Emerging Therapeutic TargetClaudia Lasalle, Rachel C Chang, Nicole C Nowak, et al.
Archives of Dermatological Research|May 21, 2025
The impact of health insurance delays on biologic therapy access in autoimmune bullous disease: a single-center retrospective analysisPaige E Adams, Elise K Brunsgaard, Nikki Rezania, et al.
Oncoscience|March 20, 2026
Targeting MD2 in prostate cancer bone metastasis: Mechanistic insights and therapeutic potentialMelina A Dattilo, Marina G Ferrari, Alexis P Jimenez-Uribe, et al.
Pageof 15